The article discusses a study which revealed that immune T cells that have been genetically engineered to express chimeric antigen receptors (CARs) using CRISPR were more effective than CAR T cells that were engineered with conventional methods. It mentions that CRISPR allows scientists to place the gene at the TRAC location in the T-cell genome.